Skip to main content
Download PDF

Detection of dynamic lung hyperinflation using cardiopulmonary exercise testing and respiratory function in patients with stable cardiac disease: a multicenter, cross-sectional study

BMC Sports Science, Medicine and Rehabilitation volume 16, Article number: 84 (2024) Cite this article

Abstract

Background

Many patients with heart disease potentially have comorbid chronic obstructive pulmonary disease (COPD); however, there are not enough opportunities for screening, and the qualitative differentiation of shortness of breath (SOB) has not been well established. We investigated the detection rate of SOB based on a visual and qualitative dynamic lung hyperinflation (DLH) detection index during cardiopulmonary exercise testing (CPET) and assessed potential differences in respiratory function between groups.

Methods

We recruited 534 patients with heart disease or patients who underwent simultaneous CPET and spirometry (369 males, 67.0 ± 12.9 years) to scrutinize physical functions. The difference between inspiratory and expiratory tidal volume was calculated (TV E-I) from the breath-by-breath data. Patients were grouped into convex (decreased TV E-I) and non-convex (unchanged or increased TV E-I) groups based on their TV E-I values after the start of exercise.

Results

Among the recruited patients, 129 (24.2%) were categorized in the convex group. There was no difference in clinical characteristics between the two groups. The Borg scale scores at the end of the CPET showed no difference. VE/VCO2 slope, its Y-intercept, and minimum VE/VCO2 showed no significant difference between the groups. In the convex group, FEV1.0/FVC was significantly lower compared to that in the non-convex group (69.4 ± 13.1 vs. 75.0 ± 9.0%). Moreover, significant correlations were observed between FEV1.0/FVC and Y-intercept (r=-0.343), as well as between the difference between minimum VE/VCO2 and VE/VCO2 slope (r=-0.478).

Conclusions

The convex group showed decreased respiratory function, suggesting a potential airway obstruction during exercise. A combined assessment of the TV E-I and Y-intercept of the VE/VCO2 slope or the difference between the minimum VE/VCO2 and VE/VCO2 slopes could potentially detect COPD or airway obstruction.

Peer Review reports

Background

Patients with cardiovascular diseases usually suffer from respiratory diseases such as chronic obstructive pulmonary disease (COPD) [1,2,3], and they develop fatigue and shortness of breath because of a variety of factors that limit exercise and activity, including lifestyle factors such as inactivity [4], increased left ventricular filling pressures [5], ventilatory-perfusion mismatch [6], and impaired oxygen delivery capacity due to cardiac dysfunction [7]. Current smoking or ex-smoking are common coronary risk factors and exacerbating factors of chronic heart failure [8,9,10,11,12]. In addition, poor lung function is an independent risk factor for cardiovascular disease and atrial fibrillation (AF) [13,14,15,16,17], and subclinical respiratory impairment is associated with the development of hypertension, which is a major risk factor for cardiovascular disease and mortality [18]. However, comorbid COPD without a history of smoking [19], potentially comorbid COPD, or respiratory impairment may not be adequately assessed, and this has not led to early detection of COPD or respiratory impairment in patients with heart disease [20].

Airflow obstruction in COPD is caused by decreased pulmonary elastic contractile pressure because of peripheral airway involvement and emphysematous lesions, resulting in collapsed airways and air trapped in the lungs during forced expiration (referred to as “air trapping”). Collapsed peripheral airways also occur during resting breathing as the disease progresses, contributing to lung hyperinflation [21]. In addition, air trapping, caused by collapsed peripheral airways, is strengthened with exertion or exercise, causing further lung hyperinflation. This is called dynamic lung hyperinflation (DLH) and is an important factor in patients with COPD, contributing to increased respiratory workload, shortness of breath on exertion, and reduced exercise tolerance [22, 23]. Although measurement of inspiratory capacity (IC) during exercise testing or the hyperventilation method has been proposed to assess DLH [24,25,26,27,28,29], opportunities for screening are insufficient. Nevertheless, there have been several reports combining exercise testing and inspiratory reserve capacity; however, there are limited reports on cardiopulmonary exercise testing (CPET), which is the most standard method of assessing exercise tolerance [30,31,32,33,34,35]. Furthermore, CPET, the gold standard for assessing exercise tolerance, provides information on the index of exercise tolerance. In CPET, the Y-intercept of the linear carbon dioxide production (V̇CO2) and minute ventilation (V̇E) relationship (the V̇E/V̇CO2 slope) is related to the severity of COPD and the forced expiratory volume (FEV) in 1 s (FEV1.0) as a percentage of forced vital capacity (FEV1.0/FVC) [36]. In our previous study, we have attempted to use CPET measurements to visually and qualitatively detect the DLH [37]. In this method, the difference between the expiratory and inspiratory tidal volumes is measured during incremental exercise, and expiration is assumed to be reduced relative to inspiration when DLH occurs.

In this study, we hypothesized that the presence or absence of the DLH index would be correlated with the CPET indices and respiratory function. We believe that by elucidating the relationship between the presence or absence of DLH indicators, CPET, and respiratory function, a comprehensive assessment of respiratory function using CPET is achievable. In addition, identifying respiratory impairment by CPET in asymptomatic or very mild stages of COPD will permit early preventive intervention and help prevent disease exacerbation.

Methods

We included 534 patients with stable heart disease or patients who underwent simultaneous CPET and spirometry testing (age: 67.0 ± 12.9 years [95% confidence interval (CI): 65.9–68.1], height:161.9 ± 9.2 cm [95% CI: 161.2–162.7], body weight:62.5 ± 14.6 kg [95% CI: 61.3–63.7], Body mass index (BMI): 23.7 ± 4.4 kg/m2 [95% CI: 23.3–24.1]) to scrutinize physical functions.

The CPET was conducted following guideline-based methods [38], using a stationary bicycle (StrengthErgo 8; Mitsubishi Electric Engineering, Tokyo, COMBI 75XL3; Konami Sports Co., Ltd., Tokyo) and a breath-by-breath analysis with a gas analyzer (AE-300 S or AE-310 S; Minato Medical Science Co., Ltd., Tokyo). The maximal symptomatic exercise was performed using the ramp protocol. The exercise protocol consisted of 2–3 min of rest and 2–3 min of warm-up. The ramp protocol was adjusted to 10–20 W/min, assuming the individual exercise tolerance level. The rating of perceived exertion (RPE) at the end of the exercise was assessed using the Borg scale.

Furthermore, a breath-by-breath gas analyzer (AE-300 S or AE-310 S; Minato Medical Science Co., Ltd., Tokyo) was used to measure the ventilatory volume of each breath using a hot-wire flowmeter [39]. Before each exercise testing, we calibrated it according to standard protocols.

Calculation of cardiopulmonary exercise testing measurements

We calculated the difference between inspiratory and expiratory tidal volumes (TV I and E, respectively) for each breathing from breath-by-breath data in each CPET [37]. Further, we have defined the difference between the expiratory and inspiratory tidal volumes as “TV E-I.” We plotted TV E-I against the time axis. In addition, we calculated the mean and standard deviation (S.D.) of TV E-I per minute based on the start of the warm-up (zero). Patients were categorized into two groups based on the TV E-I value: the convex group showing decreased TV E-I after the start of exercise, and the non-convex group displayed unchanged or increased TV E-I after the start of exercise.

We extracted other CPET parameters, such as the V̇E/V̇CO2 slope and its Y-intercept, minimum V̇E/V̇CO2, V̇O2/heart rate (HR), and dead-space gas volume to tidal volume ratio (VD/VT), for each case.

Respiratory compensation point (RCP) was comprehensively determined from the point where end-tidal carbon dioxide (ETCO2) decreases, V̇E/V̇CO2 begins to increase, and the inflection point of V̇E/V̇CO2 slope occurs [40, 41]. The relationship between V̇E and V̇CO2 was used to calculate the slope of linear regression (V̇E = aV̇CO2 + b), where “a” is the value of the V̇E vs. V̇CO2 slope, and “b” is the intercept on the V̇E axis (Y-intercept) [41, 42]. Minimum V̇E/V̇CO2 was determined as the nadir of the V̇E/V̇CO2 ratio during incremental exercise testing.

V̇O2/HR was calculated as V̇O2 divided by HR. VD/VT was calculated using the formula (ETCO2-FECO2)/ETCO2, incorporating end-tidal carbon dioxide (ETCO2) and mean expired carbon dioxide fraction (FECO2). Both indices were selected by taking the average of the resting, warm-up, and last minute of exercise.

Spirometry testing

Spirometry testing was conducted following guideline-based standard methods [43], using respiratory function testing equipment (mainly electronic diagnostic spirometer Spiroshift SP-770 COPD Fukuda Denshi Co., Tokyo).

Statistical analysis

Data were presented as mean ± standard deviation (S.D.) and 95% CIs. In addition, unpaired data were analyzed using the Student’s t-test. Moreover, paired data were analyzed using a paired t-test. Furthermore, plots of FEV1.0/FVC and Y-intercept of V̇E/V̇CO2 slope, the difference between minimum V̇E/V̇CO2 and V̇E/V̇CO2 slope were linearly regressed, and regression equations and coefficients were calculated. Statistical analyses were performed using Statistics for Excel 2012 (Social Survey Research Information Co., Tokyo, Japan).

Ethics approval and consent to participate

The study was conducted following the principles outlined in the Declaration of Helsinki and approved by the ethical committees of Hakodate National Hospital (approval number: R4-0314001) and Gunma Prefectural Cardiovascular Center (approval number:2,022,020).

The need for informed consent was waived by the ethics committee of Hakodate National Hospital (approval number: R4-0314001) and Gunma Prefectural Cardiovascular Center (approval number:2,022,020) because of the retrospective nature of the study. The data obtained were delinked and anonymized, and this study was conducted using the data for analysis, with due consideration for protecting the participants’ personal information. The authors confirm that none of the participants could be identified and that they were fully anonymized. Furthermore, the authors affirm that all mandatory health and safety procedures complied with the course of conducting the experimental work reported in this paper.

Results

There were no differences in physical parameters between the convex and non-convex groups; however, there were significantly more males in the convex group. Although there was no significant difference in smoking history between the two groups [Smoking history (+:-) Total 339:195, convex 85:44, non-convex 254:151, p = 0.514], the convex group had more severe cases when the GOLD classification was applied [GOLD classification (0:I: II: III: IV); total 397:86:39:9:3, convex 79:24:15:8:3, non-convex 318:62:24:1:0, p < 0.001; Table 1].

Table 1 Data of participants’ clinical characteristics
Full size table

Furthermore, all the participants underwent symptomatic maximal CPET. Moreover, there were 129 patients in the convex group with decreased TV E-I during CPET and 405 patients in the non-convex group. Although the RPE at the end of the exercise test showed no difference in shortness of breath between the two groups, lower extremity fatigue was significantly lower in the convex group.

The indices of cardiopulmonary exercise testing

A list of typical CPET parameters is shown in Table 2. There were no significant differences in the exercise tolerance indices between the two groups. Although there were no differences in the V̇E/V̇CO2 slope and Y-intercept between the two groups, the minimum V̇E/V̇CO2 tended to be higher in the convex group.

Table 2 Cardiopulmonary exercise testing indices
Full size table

The indices of spirometry testing

A list of typical spirometry testing parameters is shown in Table 3. Vital capacity (VC), tidal volume (TV), expiratory reverse volume (ERV), and inspiratory reverse volume (IRV) did not differ significantly. However, the convex group had significantly lower FEV1.0/FVC and predictive rates for FEV1.0/FVC, % PEF, and % MVV.

Table 3 Spirometry testing indices
Full size table

Relationship between exhaled gas analysis index and spirometry testing

In the convex group, Y-intercept and FEV1.0/FVC showed a significant negative correlation (convex; r=-0.343 [-0.487 ≦ ρ≦-0.181], p < 0.001, non-convex; r=-0.090 [-0.186 ≦ ρ ≦ 0.008], p = 0.070; Fig. 1 (A-1, 2)).

Fig. 1
figure 1

Correlation between respiratory function and cardiopulmonary exercise testing (CPET) indices. The upper two panels show the relationship between FEV1.0/FVC and the Y-intercept of V̇E/V̇CO2 in the convex group (A-1) and the non-convex group (A-2). The lower two panels show the relationship between FEV1.0/FVC and the difference between the minimum V̇E/V̇CO2 and V̇E/V̇CO2 slopes in the convex (B-1) and non-convex groups (B-2). V̇E/V̇CO2: ventilatory equivalent for carbon dioxide production; FEV1.0/FVC: forced expiratory volume in 1 s as a percent of forced vital capacity;

Full size image

V̇E/V̇CO2 slope and minimum V̇E/V̇CO2 showed insignificant correlation with FEV1.0/FVC; however, there was a significant negative correlation with the difference between V̇E/V̇CO2 slope and minimum V̇E/V̇CO2 (convex: r=-0.478 [-0.601 ≦ ρ≦-0.333], p < 0.001; non-convex: r=-0.137 [-0.231 ≦ ρ≦-0.040], p = 0.006; Fig. 1 (B-1, 2)).

Discussion

This study stands out as one of the few studies examining the relationship between differences in respiratory function and CPET indices, based on the qualitative detection of DLH using CPET. DLH is a physiological respiratory mechanism in which expiration occurs less than inspiration, with an increased respiratory rate. Past studies have measured a decrease in IC or an increase in EELV during exercise [44]. Nevertheless, our study reveals that DLH can be readily detected and correlated with respiratory function by analyzing data from exhaled gas analyses, thereby supporting the underlying theory.

Respiratory function by spirometry testing

Respiratory functions, such as VC and TV, did not differ between the two groups; however, FEV1.0/FVC, % MVV, and % PEF were lower in the convex group. In the convex group, the mean value of FEV1.0/FVC was equivalent to the diagnostic criteria for obstructive ventilatory impairment. In contrast, in the non-convex group, most cases did not meet the criteria for GOLD stage 1, and several cases were not diagnosed as having obstructive ventilation impairment on spirometry testing. Nevertheless, several patients in the convex group likely had DLH because of peripheral airway obstruction (stenosis) or other factors, as they had less expiration than inspiration during the exercise. Therefore, it is possible that respiratory function had already declined before meeting the criteria for diagnosis of DLH, due to the obstruction of the small bronchioles and other organs. Furthermore, it has already been shown that subclinical respiratory impairment may also affect cardiovascular function and cardiovascular disease [13,14,15,16,17,18]. Although this was a cross-sectional study and the outcome of very mild cases was unknown, we believe that TV E-I may be a qualitative indicator of peripheral airway obstruction.

Relationship between cardiopulmonary exercise testing indices and dynamic pulmonary hyperinflation

Ventilatory efficiency decreases because of congestion caused by heart failure and obstructive ventilation impairment [41]. For instance, in patients with heart failure, the minimum V̇E/V̇CO2 and V̇E/V̇CO2 slope increase with disease severity; however, they are generally consistent [45]. In contrast, in COPD, the V̇E/V̇CO2 slope increases in mild disease but decreases in severe disease [46, 47]. Furthermore, in COPD, the Y-intercept of the V̇E/V̇CO2 slope is related to FEV1.0/FVC and the Y-intercept is higher [36]. Murata et al. reported that as COPD progresses, the minimum V̇E/V̇CO2 and V̇E/V̇CO2 slopes may diverge, or the V̇E/V̇CO2 slope may become pseudo-negative, and the Y-intercept may be high [36, 48]. However, the decrease in IC or increase in EELV during exercise is fundamental to the evaluation of DLH; both indices only report observational studies on COPD and do not examine the presence or absence of DLH or its extent.

Although the convex group showed a trend towards a higher minimum V̇E/V̇CO2 in this study, there were no significant differences in these indices between the two groups, including the Y-intercept and V̇E/V̇CO2 slope. However, even in such cases, FEV1.0/FVC and the Y-intercept of the V̇E/V̇CO2 slope showed a significant correlation in the convex group, similar to the results of previous studies. Furthermore, FEV1.0/FVC also showed a significant negative correlation with the difference between the minimum V̇E/V̇CO2 ratio and the V̇E/V̇CO2 slope. In contrast, in the non-convex group, the correlation between the difference in minimum V̇E/V̇CO2 and V̇E/V̇CO2 slope and FEV1.0/FVC was very limited, indicating that a combined evaluation with TV E-I is crucial.

Although the study group had milder respiratory function impairment than those in previous studies, it was suggested that the combined TV E-I and Y-intercept or the difference between the minimum V̇E/V̇CO2 and V̇E/V̇CO2 slope during incremental exercise testing could provide an index of respiratory function and an assessment of the severity of peripheral airway obstruction in patients with stable cardiac disease.

The usefulness of detecting dynamic lung hyperinflation using cardiopulmonary exercise test

Most participants in this study had stable heart disease and mild respiratory function impairment. However, 63.4% of the patients had a smoking history, and more than 20% showed the possibility of DLH on CPET. Interestingly, the prevalence of COPD is expected to decrease in high-income countries as smoking declines; however, it will become a major social problem in low-to-middle-income countries [49]. COPD causes chronic systemic inflammation, leading to a decline in physical function and a worsening prognosis [50]. Moreover, DLH increases the respiratory workload and restricts venous return [51], leading to exercise limitation and static lung hyperinflation caused by COPD progression and a worsened prognosis [49, 52, 53].

We believe that capturing respiratory changes associated with increased exercise intensity using CPET, as demonstrated in this study, provides a simple and qualitative method for detecting airway stenosis and DLH at an early stage, even in patients with mild symptoms or asymptomatic disease. Furthermore, we believe this will lead to early scrutiny, appropriate therapeutic interventions, and drug prescriptions, ultimately improving the quality of life and patient prognosis.

Limitations

There are some limitations to this study. First, this was a cross-sectional study; moreover, cardiopulmonary exercise and spirometry testing were not often performed at approximately the same time, possibly resulting in a selection bias (comorbidity of DLH). In addition, the course of the patients’ conditions in this study was unclear, including whether there was a worsening shortness of breath and other symptoms, a progressive decline in respiratory function, or a diagnosis of COPD. Therefore, further studies are warranted.

Second, the study did not compare the results with those of the existing DLH assessment methods or evaluate the response to bronchodilator use. Therefore, it is difficult to confirm the presence of DLH based on the results of this study alone.

Third, several participants in this study had relatively preserved respiratory function. Therefore, it is uncertain whether a similar trend would be observed in patients with moderate-to-severe COPD who have already been diagnosed. Finally, it is currently difficult to determine the severity of DLH; therefore, developing appropriate analytical methods for TV E-I is desirable.

Conclusion

Evaluating data on differences in TV E-I during cardiopulmonary exercise testing has proven useful for DLH in patients with stable heart disease. The combined evaluation of the TV E-I and Y-intercept of the V̇E/V̇CO2 slope or the difference between the minimum V̇E/V̇CO2 and V̇E/V̇CO2 slopes in CPET, could detect cases of potential respiratory impairment or peripheral airway obstruction.

Data availability

The dataset used in this study is available from the corresponding author upon request.

Abbreviations

VAT:

ventilatory anaerobic threshold

Inc-Ex:

incremental exercise

CPET:

Cardiopulmonary exercise testing

V̇O2 :

Oxygen uptake

V̇CO2 :

carbon dioxide production

V̇E:

ventilatory equivalent

RPE:

Rating of perceived exertion

RR:

respiratory rate

VD/VT:

dead-space gas volume to tidal volume ratio

COPD:

chronic obstructive pulmonary disease

DLH:

dynamic lung hyperinflation

TV:

tidal volume

TV I:

inspiratory tidal volume

TV E:

expiratory tidal volume

FEV:

forced expiratory volume

FEV1.0:

forced expiratory volume in 1 s

FEV1.0/FVC:

forced expiratory volume in 1 s as a percent of forced vital capacity

VC:

vital capacity

IC:

inspiratory capacity

S.D.:

standard deviation

CI:

confidence interval

References

  1. Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail. 2009;11:130–9. https://doi.org/10.1093/eurjhf/hfn013.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Correale M, Paolillo S, Mercurio V, Ruocco G, Tocchetti CG, Palazzuoli A. Non-cardiovascular comorbidities in heart failure patients and their impact on prognosis. Kardiol Pol. 2021;79:493–502. https://doi.org/10.33963/KP.15934.

    Article  PubMed  Google Scholar 

  3. Anker SD, Butler J, Filippatos G, Shahzeb Khan M, Ferreira JP, Bocchi E, et al. EMPEROR-Preserved trial committees and investigators. Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial. Eur J Heart Fail. 2020;22:2383–92. https://doi.org/10.1002/ejhf.2064.

    Article  CAS  PubMed  Google Scholar 

  4. Okita K, Kinugawa S, Tsutsui H. Exercise intolerance in chronic heart failure–skeletal muscle dysfunction and potential therapies. Circ J. 2013;77:293–300. https://doi.org/10.1253/circj.cj-12-1235.

    Article  CAS  PubMed  Google Scholar 

  5. Sekiguchi M, Adachi H, Oshima S, Taniguchi K, Hasegawa A, Kurabayashi M. Effect of changes in left ventricular diastolic function during exercise on exercise tolerance assessed by exercise-stress tissue Doppler echocardiography. Int Heart J. 2009;50:763–71. https://doi.org/10.1536/ihj.50.763.

    Article  PubMed  Google Scholar 

  6. Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF, et al. Clinician’s guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010;122:191–225. https://doi.org/10.1161/CIR.0b013e3181e52e69.

    Article  PubMed  Google Scholar 

  7. Pandey A, Shah SJ, Butler J, Kellogg DL Jr, Lewis GD, Forman DE, et al. Exercise intolerance in older adults with heart failure with preserved ejection fraction: JACC state-of-the-art review. J Am Coll Cardiol. 2021;78:1166–87. https://doi.org/10.1016/j.jacc.2021.07.014.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Siasos G, Tsigkou V, Kokkou E, Oikonomou E, Vavuranakis M, Vlachopoulos C, et al. Smoking and atherosclerosis: mechanisms of disease and new therapeutic approaches. Curr Med Chem. 2014;21:3936–48. https://doi.org/10.2174/092986732134141015161539.

    Article  CAS  PubMed  Google Scholar 

  9. Kamimura D, Cain LR, Mentz RJ, White WB, Blaha MJ, DeFilippis AP, et al. Cigarette smoking and incident heart failure: insights from the Jackson Heart Study. Circulation. 2018;137:2572–82. https://doi.org/10.1161/CIRCULATIONAHA.117.031912.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Suskin N, Sheth T, Negassa A, Yusuf S. Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. J Am Coll Cardiol. 2001;37:1677–82. https://doi.org/10.1016/s0735-1097(01)01195-0.

    Article  CAS  PubMed  Google Scholar 

  11. van Oort S, Beulens JWJ, van Ballegooijen AJ, Handoko ML, Larsson SC. Modifiable lifestyle factors and heart failure: a mendelian randomization study. Am Heart J. 2020;227:64–73. https://doi.org/10.1016/j.ahj.2020.06.007.

    Article  CAS  PubMed  Google Scholar 

  12. Lu Y, Xu Z, Georgakis MK, Wang Z, Lin H, Zheng L. Smoking and heart failure: a mendelian randomization and mediation analysis. ESC Heart Fail. 2021;8:1954–65. https://doi.org/10.1002/ehf2.13248.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Johnson LS, Juhlin T, Engström G, Nilsson PM. Reduced forced expiratory volume is associated with increased incidence of atrial fibrillation: the Malmo Preventive Project. Europace. 2014;16:182–8. https://doi.org/10.1093/europace/eut255.

    Article  PubMed  Google Scholar 

  14. Chahal H, Heckbert SR, Barr RG, Bluemke DA, Jain A, Habibi M, et al. Ability of reduced lung function to predict development of atrial fibrillation in persons aged 45 to 84 years (from the multi-ethnic study of atherosclerosis-lung study). Am J Cardiol. 2015;115:1700–4. https://doi.org/10.1016/j.amjcard.2015.03.018.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Li J, Agarwal SK, Alonso A, Blecker S, Chamberlain AM, London SJ, et al. Airflow obstruction, lung function, and incidence of atrial fibrillation: the atherosclerosis risk in communities (ARIC) study. Circulation. 2014;129:971–80. https://doi.org/10.1161/CIRCULATIONAHA.113.004050.

    Article  PubMed  Google Scholar 

  16. Engström G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, et al. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation. 2002;106:2555–60. https://doi.org/10.1161/01.cir.0000037220.00065.0d.

    Article  PubMed  Google Scholar 

  17. Wang B, Zhou Y, Xiao L, Guo Y, Ma J, Zhou M, et al. Association of lung function with cardiovascular risk: a cohort study. Respir Res. 2018;19:214. https://doi.org/10.1186/s12931-018-0920-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Jacobs DR Jr, Yatsuya H, Hearst MO, Thyagarajan B, Kalhan R, Rosenberg S, et al. Rate of decline of forced vital capacity predicts future arterial hypertension: the coronary artery risk development in young adults study. Hypertension. 2012;59:219–25. https://doi.org/10.1161/HYPERTENSIONAHA.111.184101.

    Article  CAS  PubMed  Google Scholar 

  19. Yang IA, Jenkins CR, Salvi SS. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment. Lancet Respir Med. 2022;10:497–511. https://doi.org/10.1016/S2213-2600(21)00506-3.

    Article  CAS  PubMed  Google Scholar 

  20. Ramalho SHR, Shah AM. Lung function and cardiovascular disease: a link. Trends Cardiovasc Med. 2021;31:93–8. https://doi.org/10.1016/j.tcm.2019.12.009.

    Article  PubMed  Google Scholar 

  21. Kurosawa H, Kohzuki M. Images in clinical medicine. Dynamic airway narrowing. N Engl J Med. 2004;350:1036. https://doi.org/10.1056/NEJMicm030626.

    Article  CAS  PubMed  Google Scholar 

  22. O’Donnell DE, Hamilton AL, Webb KA. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. J Appl Physiol (1985). 2006;101:1025–35. https://doi.org/10.1152/japplphysiol.01470.2005.

    Article  PubMed  Google Scholar 

  23. Stringer W, Marciniuk D. The role of cardiopulmonary exercise testing (CPET) in pulmonary rehabilitation (PR) of chronic obstructive pulmonary disease (COPD) patients. COPD. 2018;15:621–31. https://doi.org/10.1080/15412555.2018.1550476.

    Article  PubMed  Google Scholar 

  24. Fujimoto K, Kitaguchi Y, Kanda S, Urushihata K, Hanaoka M, Kubo K. Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:219–27. https://doi.org/10.2147/COPD.S18461.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Fujimoto K, Yamazaki H, Ura M, Kitaguchi Y. Efficacy of tiotropium and indacaterol monotherapy and their combination on dynamic lung hyperinflation in COPD: a random open-label crossover study. Int J Chron Obstruct Pulmon Dis. 2017;12:3195–201. https://doi.org/10.2147/COPD.S149054.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Fujimoto K, Yoshiike F, Yasuo M, Kitaguchi Y, Urushihata K, Kubo K, et al. Effects of bronchodilators on dynamic hyperinflation following hyperventilation in patients with COPD. Respirology. 2007;12:93–9. https://doi.org/10.1111/j.1440-1843.2006.00963.x.

    Article  PubMed  Google Scholar 

  27. Kawachi S, Fujimoto K. Metronome-paced incremental hyperventilation may predict exercise tolerance and dyspnea as a surrogate for dynamic lung hyperinflation during exercise. Int J Chron Obstruct Pulmon Dis. 2020;15:1061–9. https://doi.org/10.2147/COPD.S246850.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kawachi S, Fujimoto K. Efficacy of tiotropium and olodaterol combination therapy on dynamic lung hyperinflation evaluated by hyperventilation in COPD: an open-label, comparative before and after treatment study. Int J Chron Obstruct Pulmon Dis. 2019;14:1167–76. https://doi.org/10.2147/COPD.S201106.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Roesthuis LH, van der Hoeven JG, Guérin C, Doorduin J, Heunks LMA. Three bedside techniques to quantify dynamic pulmonary hyperinflation in mechanically ventilated patients with chronic obstructive pulmonary disease. Ann Intensive Care. 2021;11:167. https://doi.org/10.1186/s13613-021-00948-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Satake M, Shioya T, Uemura S, Takahashi H, Sugawara K, Kasai C, et al. Dynamic hyperinflation and dyspnea during the 6-minute walk test in stable chronic obstructive pulmonary disease patients. Int J Chron Obstruct Pulmon Dis. 2015;10:153–8. https://doi.org/10.2147/COPD.S73717.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Alfonso M, Bustamante V, Cebollero P, Antón M, Herrero S, Gáldiz JB. Assessment of dyspnea and dynamic hyperinflation in male patients with chronic obstructive pulmonary disease during a six minute walk test and an incremental treadmill cardiorespiratory exercise test. Rev Port Pneumol (2006). 2017;23:266– 72. https://doi.org/10.1016/j.rppnen.2017.04.007.

  32. Chen R, Lin L, Tian JW, Zeng B, Zhang L, Chen X, Yan HY. Predictors of dynamic hyperinflation during the 6-minute walk test in stable chronic obstructive pulmonary disease patients. J Thorac Dis. 2015;7:1142–50. https://doi.org/10.3978/j.issn.2072-1439.2015.07.08.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Cordoni PK, Berton DC, Squassoni SD, Scuarcialupi ME, Neder JA, Fiss E. Dynamic hyperinflation during treadmill exercise testing in patients with moderate to severe COPD. J Bras Pneumol. 2012;38:13–23. https://doi.org/10.1590/s1806-37132012000100004.

    Article  PubMed  Google Scholar 

  34. Shiraishi M, Higashimoto Y, Sugiya R, Mizusawa H, Takeda Y, Fujita S, et al. Diaphragmatic excursion correlates with exercise capacity and dynamic hyperinflation in COPD patients. ERJ Open Res. 2020;6:00589–2020. https://doi.org/10.1183/23120541.00589-2020.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Vieira DSR, Mendes LPS, Alencar MCN, Hoffman M, Albuquerque ALP, Silveira BMF, et al. Rib cage distortion and dynamic hyperinflation during two exercise intensities in people with COPD. Respir Physiol Neurobiol. 2021;293:103724. https://doi.org/10.1016/j.resp.2021.103724.

    Article  PubMed  Google Scholar 

  36. Teopompi E, Tzani P, Aiello M, Ramponi S, Visca D, Gioia MR, et al. Ventilatory response to carbon dioxide output in subjects with congestive heart failure and in patients with COPD with comparable exercise capacity. Respir Care. 2014;59:1034–41. https://doi.org/10.4187/respcare.02629.

    Article  PubMed  Google Scholar 

  37. Kominami K, Noda K, Minagawa N, Yonezawa K, Akino M. The concept of detection of dynamic lung hyperinflation using cardiopulmonary exercise testing. Med (Baltim). 2023;102:e33356. https://doi.org/10.1097/MD.0000000000033356.

    Article  CAS  Google Scholar 

  38. American Thoracic Society. American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211–77. https://doi.org/10.1164/rccm.167.2.211.

    Article  Google Scholar 

  39. Yoshiya I, Nakajima T, Nagai I, Jitsukawa S. A bidirectional respiratory flowmeter using the hot-wire principle. J Appl Physiol. 1975;38:360–5. https://doi.org/10.1152/jappl.1975.38.2.360.

    Article  CAS  PubMed  Google Scholar 

  40. Stringer W, Casaburi R, Wasserman K. Acid-base regulation during exercise and recovery in humans. J Appl Physiol (1985). 1992;72:954–61. https://doi.org/10.1152/jappl.1992.72.3.954.

  41. Wasserman K, Hansen JE, Sue DY, Stringer WW, Sietsema KE, Sun X-G. Principles of exercise testing and interpretation: including pathophysiology and clinical application. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2012.

  42. Sun XG, Hansen JE, Garatachea N, Storer TW, Wasserman K. Ventilatory efficiency during exercise in healthy subjects. Am J Respir Crit Care Med. 2002;166:1443–8. https://doi.org/10.1164/rccm.2202033.

  43. Kubota M, Kobayashi H, Quanjer PH, Omori H, Tatsumi K, Kanazawa M, Clinical Pulmonary Functions Committee of the Japanese Respiratory Society. Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. Respir Investig. 2014;52:242–50. https://doi.org/10.1016/j.resinv.2014.03.003.

    Article  PubMed  Google Scholar 

  44. Boutou AK, Zafeiridis A, Pitsiou G, Dipla K, Kioumis I, Stanopoulos I. Cardiopulmonary exercise testing in chronic obstructive pulmonary disease: an update on its clinical value and applications. Clin Physiol Funct Imaging. 2020;40:197–206. https://doi.org/10.1111/cpf.12627.

    Article  PubMed  Google Scholar 

  45. Santoro C, Sorrentino R, Esposito R, Lembo M, Capone V, Rozza F, et al. Cardiopulmonary exercise testing and echocardiographic exam: an useful interaction. Cardiovasc Ultrasound. 2019;17:29. https://doi.org/10.1186/s12947-019-0180-0.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Neder JA, Arbex FF, Alencar MC, O’Donnell CD, Cory J, Webb KA, et al. Exercise ventilatory inefficiency in mild to end-stage COPD. Eur Respir J. 2015;45:377–87. https://doi.org/10.1183/09031936.00135514.

    Article  PubMed  Google Scholar 

  47. Gargiulo P, Apostolo A, Perrone-Filardi P, Sciomer S, Palange P, Agostoni P. A non invasive estimate of dead space ventilation from exercise measurements. PLoS ONE. 2014;9:e87395. https://doi.org/10.1371/journal.pone.0087395.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Murata M, Kobayashi Y, Adachi H. Examination of the relationship and dissociation between minimum minute ventilation/carbon dioxide production and minute ventilation vs. carbon dioxide production slope. Circ J. 2021;86:79–86. https://doi.org/10.1253/circj.CJ-21-0261.

    Article  PubMed  Google Scholar 

  49. Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I, NIHR RESPIRE Global Respiratory Health Unit. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10:447–58. https://doi.org/10.1016/S2213-2600(21)00511-7.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379:1341–51. https://doi.org/10.1016/S0140-6736(11)60968-9.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Frazão M, Silva PE, Frazão W, da Silva VZM, Correia MAV Jr, Neto MG. Dynamic hyperinflation impairs cardiac performance during exercise in COPD. J Cardiopulm Rehabil Prev. 2019;39:187–92. https://doi.org/10.1097/HCR.0000000000000325.

    Article  PubMed  Google Scholar 

  52. Cavaillès A, Brinchault-Rabin G, Dixmier A, Goupil F, Gut-Gobert C, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22:454–75. https://doi.org/10.1183/09059180.00008612.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Ritchie AI, Wedzicha JA. Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations. Clin Chest Med. 2020;41:421–38. https://doi.org/10.1016/j.ccm.2020.06.007.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to thank Editage for assistance in English language editing.

The results of the study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation, and the results of the present study do not constitute endorsement by BMC Sports Science, Medicine, and Rehabilitation.

Funding

This study did not receive any funding support.

Author information

Authors and Affiliations

  1. Department of Rehabilitation, Sanseikai Kitano Hospital, 6-30, 1-chome, Kitano 1-jyo, Kiyota-ku, 004-0861, Sapporo, Hokkaido, Japan

    Kazuyuki Kominami

  2. Department of Rehabilitation, National Hospital Organization Hakodate Hospital, Hakodate, Japan

    Kazuki Noda

  3. Sinfuwakai Asabu Heart and Cardiac Rehabilitation Clinic, Sapporo, Hokkaido, Japan

    Nanaho Minagawa

  4. Department of Cardiovascular Medicine, National Hospital Organization Hakodate Hospital, Hakodate, Hokkaido, Japan

    Kazuya Yonezawa

  5. Department of Clinical Laboratory, Gunma Prefectural Cardiovascular Center, Maebashi, Gunma, Japan

    Masanori Ueda & Yasuyuki Kobayashi

  6. Department of Cardiology, Gunma Prefectural Cardiovascular Center, Maebashi, Gunma, Japan

    Makoto Murata

  7. Department of Internal Medicine, Sapporo Kiyota Hospital, Sapporo, Hokkaido, Japan

    Masatoshi Akino

Authors
  1. Kazuyuki Kominami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kazuki Noda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nanaho Minagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazuya Yonezawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masanori Ueda
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yasuyuki Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Makoto Murata
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Masatoshi Akino
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

KK, MM, and MA developed the study concept and were involved in its design and implementation. KK, KN, NM, and MM delivered program content to the participants. KK, KN, NM, MU, YK, and MM acquired data. KK analyzed the data. KK and MM prepared the manuscript. KN, MN, KY, and MA drafted the manuscript and approved the final draft. All the authors have read and approved the final version of the manuscript.

Corresponding author

Correspondence to Kazuyuki Kominami.

Ethics declarations

Ethics approval and consent to participate

The study was conducted following the principles outlined in the Declaration of Helsinki and approved by the ethical committees of Hakodate National Hospital (approval number: R4-0314001) and Gunma Prefectural Cardiovascular Center (approval number:2022020). The need for written informed consent was waived by the two ethical committees mentioned above due to the retrospective nature of the study. The data obtained were delinked and anonymized, and this study was conducted using the data for analysis, with due consideration for protecting the participants’ personal information. The authors confirmed that none of the participants could be identified and that they were fully anonymized. Furthermore, the authors affirmed that all mandatory health and safety procedures complied with the course of conducting the experimental work reported in this paper.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kominami, K., Noda, K., Minagawa, N. et al. Detection of dynamic lung hyperinflation using cardiopulmonary exercise testing and respiratory function in patients with stable cardiac disease: a multicenter, cross-sectional study. BMC Sports Sci Med Rehabil 16, 84 (2024). https://doi.org/10.1186/s13102-024-00871-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13102-024-00871-z

Keywords

BMC Sports Science, Medicine and Rehabilitation

ISSN: 2052-1847

Contact us